CAPTRUST FINANCIAL ADVISORS - LEAP THERAPEUTICS INC ownership

LEAP THERAPEUTICS INC's ticker is LPTX and the CUSIP is 52187K101. A total of 84 filers reported holding LEAP THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of LEAP THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$3,400
-62.2%
10,0000.0%0.00%
Q3 2022$9,000
+80.0%
10,000
+150.0%
0.00%
Q2 2022$5,000
-28.6%
4,0000.0%0.00%
Q1 2022$7,000
-46.2%
4,0000.0%0.00%
Q4 2021$13,0004,0000.00%
Other shareholders
LEAP THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Sio Capital Management, LLC 476,223$533,0000.13%
683 Capital Management, LLC 150,142$168,0000.02%
Alyeska Investment Group, L.P. 514,285$576,0000.01%
Baker Brothers Advisors 978,454$1,096,0000.01%
Quilter Plc 50,000$56,0000.00%
Schonfeld Strategic Advisors LLC 80,319$90,0000.00%
FMR LLC 660,800$740,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
Lionsbridge Wealth Management LLC 181$00.00%
GEODE CAPITAL MANAGEMENT, LLC 328,986$368,0000.00%
View complete list of LEAP THERAPEUTICS INC shareholders